empower pharmacy lawsuit semaglutide Ozempic [July 2026 Update] FDA free to pursue semaglutide

Retatrutide, through its powerful GLP-1 and GIP agonism, dramatically improves insulin sensitivity and lowers circulating insulin levels

This dual action reduces appetite and slows gastric emptying (the rate at which food leaves your stomach) more effectively than medications that mimic GLP-1 alone

10.1089/105072501750362709 7 BarchettaI.CiminiF

Both medications are available in Australia, with Ozempic PBS-subsidised for diabetes and Wegovy privately available

The three main channels each have distinct pricing structures

Cognitive & Neurological Support: GLP-1s may have neuroprotective effects, potentially lowering the risk of degenerative brain conditions like Alzheimers